Literature DB >> 16565012

Toxic anterior segment syndrome.

Nick Mamalis1, Henry F Edelhauser, Daniel G Dawson, Jesse Chew, Russell M LeBoyer, Liliana Werner.   

Abstract

Toxic anterior segment syndrome (TASS) is a sterile postoperative inflammatory reaction caused by a noninfectious substance that enters the anterior segment, resulting in toxic damage to intraocular tissues. The process typically starts 12 to 48 hours after cataract/anterior segment surgery, is limited to the anterior segment of the eye, is always Gram stain and culture negative, and usually improves with steroid treatment. The primary differential diagnosis is infectious endophthalmitis. Review of the literature indicates that possible causes of TASS include intraocular solutions with inappropriate chemical composition, concentration, pH, or osmolality; preservatives; denatured ophthalmic viscosurgical devices; enzymatic detergents; bacterial endotoxin; oxidized metal deposits and residues; and factors related to intraocular lenses such as residues from polishing or sterilizing compounds. An outbreak of TASS is an environmental and toxic control issue that requires complete analysis of all medications and fluids used during surgery, as well as complete review of operating room and sterilization protocols.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16565012     DOI: 10.1016/j.jcrs.2006.01.065

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  41 in total

Review 1.  The microbiology of endophthalmitis: global trends and a local perspective.

Authors:  Y Keynan; Y Finkelman; P Lagacé-Wiens
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-05       Impact factor: 3.267

2.  Toxic anterior segment syndrome - A sequel of uneventful cataract surgery.

Authors:  P S Moulick; Sridhara Reddy; V S Gurunadh; V K Mohindra
Journal:  Med J Armed Forces India       Date:  2014-04-03

3.  Self-inflicted injection of tattoo ink in the anterior chamber: a failed attempt to change the color of the eyes.

Authors:  José D Paulo; Juan Carlos Mejía Turizo; Diana Carolina Montoya Carrasquilla; Luisa Maria Bustamante
Journal:  Digit J Ophthalmol       Date:  2018-06-30

4.  Safety of prophylactic intracameral moxifloxacin ophthalmic solution after cataract surgery in patients with penetrating keratoplasty.

Authors:  Osman Sevki Arslan; Ceyhun Arici; Mustafa Unal; Erdogan Cicik; Mehmet Serhat Mangan; Eray Atalay
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

5.  Comparison of the influence of intracameral gentamicin, gatifloxacin, and moxifloxacin on the corneal endothelium in a rabbit model.

Authors:  Shinichiro Kobayakawa; Yoshimune Hiratsuka; Yasuo Watabe; Akira Murakami; Tetsuo Tochikubo
Journal:  Jpn J Ophthalmol       Date:  2010-11-05       Impact factor: 2.447

6.  Intraocular lens implantation without the use of ophthalmic viscosurgical device.

Authors:  Ugur Unsal; Gonen Baser; Mehmet Soyler
Journal:  Int Ophthalmol       Date:  2016-03-14       Impact factor: 2.031

7.  Emerging Worldwide Antimicrobial Resistance, Antibiotic Stewardship and Alternative Intravitreal Agents for the Treatment of Endophthalmitis.

Authors:  Nidhi Relhan; Avinash Pathengay; Stephen G Schwartz; Harry W Flynn
Journal:  Retina       Date:  2017-05       Impact factor: 4.256

8.  Endogenous endophthalmitis caused by Citrobacter koseri originating from a renal abscess.

Authors:  Jeremy He Cong'En; Mijan Miah; Benjamin Sünkel-Laing; Julian Emmanuel
Journal:  BMJ Case Rep       Date:  2014-08-05

9.  Assessing the accuracy of intracameral phenylephrine preparation in cataract surgery.

Authors:  Stuart Guthrie; Thomas Jensen; Richard C Hartley; Kanna Ramaesh; David Lockington
Journal:  Eye (Lond)       Date:  2018-06-15       Impact factor: 3.775

10.  Endophthalmitis: A review of recent trends.

Authors:  Janice R Safneck
Journal:  Saudi J Ophthalmol       Date:  2012-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.